文献速递精神分裂症与精神病性障碍心境障碍

胰岛素对精神分裂症神经生物学核心神经递质通路的影响:临床前研究的荟萃分析及其治疗意义

Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment.
PubMed 文献 · Mol Psychiatry · 2023-04-21

结果显示胰岛素抵抗动物模型中NMDAR亚基NR2A、NR2B和PSD-95蛋白水平降低,胰岛素缺乏条件下多巴胺D2受体mRNA表达增加,提示脑神经递质系统易受胰岛素信号异常影响,可能参与难治性精神分裂症神经生物学标志的形成。

要点

  • 胰岛素抵抗动物模型中NMDAR亚基NR2A、NR2B及PSD-95蛋白水平显著降低。
  • 胰岛素缺乏条件下多巴胺D2受体mRNA表达显著增加。
  • 胰岛素作用调节谷氨酸和GABA释放及GABA、5-羟色胺合成相关酶。

核心结论

  • 脑神经递质系统易受胰岛素信号异常影响,类似精神分裂症神经生物学改变,可能促进难治性精神分裂症神经生物学标志的发展。

主要发现

  • 胰岛素抵抗动物模型中NMDAR亚基NR2A蛋白水平降低(Hedges'g=-0.95,95%CI=-1.50,-0.39;p=0.001;I2=47.46%)。
  • 胰岛素抵抗动物模型中NMDAR亚基NR2B蛋白水平降低(Hedges'g=-0.69,95%CI=-1.35,-0.02;p=0.043;I2=62.09%)。
  • 胰岛素抵抗动物模型中PSD-95蛋白水平降低(Hedges'g=-0.91,95%CI=-1.51,-0.32;p=0.003;I2=77.81%)。
  • 胰岛素抵抗动物显示多巴胺转运体活性显著受损。
  • 胰岛素缺乏条件下多巴胺D2受体mRNA表达增加(Hedges'g=3.259;95%CI=0.497,6.020;p=0.021;I2=90.61%)。

临床怎么用

  • 提示临床关注精神分裂症患者的胰岛素信号异常,可能作为改善神经递质通路异常的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Impairment of insulin action and metabolic dysregulation have traditionally been associated with schizophrenia, although the molecular basis of such association remains still elusive. The present meta-analysis aims to assess the impact of insulin action manipulations (i.e., hyperinsulinemia, hypoinsulinemia, systemic or brain insulin resistance) on glutamatergic, dopaminergic, γ-aminobutyric acid (GABA)ergic, and serotonergic pathways in the central nervous system. More than one hundred outcomes, including transcript or protein levels, kinetic parameters, and other components of the neurotransmitter pathways, were collected from cultured cells, animals, or humans, and meta-analyzed by applying a random-effects model and adopting Hedges'g to compare means. Two hundred fifteen studies met the inclusion criteria, of which 180 entered the quantitative synthesis. Significant impairments in key regulators of synaptic plasticity processes were detected as the result of insulin handlings. Specifically, protein levels of N-methyl-D-aspartate receptor (NMDAR) subunits including type 2A (NR2A) (Hedges' g = -0.95, 95%C.I. = -1.50, -0.39; p = 0.001; I2 = 47.46%) and 2B (NR2B) (Hedges'g = -0.69, 95%C.I. = -1.35, -0.02; p = 0.043; I2 = 62.09%), and Postsynaptic density protein 95 (PSD-95) (Hedges'g = -0.91, 95%C.I. = -1.51, -0.32; p = 0.003; I2 = 77.81%) were found reduced in insulin-resistant animal models. Moreover, insulin-resistant animals showed significantly impaired dopamine transporter activity, whereas the dopamine D2 receptor mRNA expression (Hedges'g = 3.259; 95%C.I. = 0.497, 6.020; p = 0.021; I2 = 90.61%) increased under insulin deficiency conditions. Insulin action modulated glutamate and GABA release, as well as several enzymes involved in GABA and serotonin synthesis. These results suggest that brain neurotransmitter systems are susceptible to insulin signaling abnormalities, resembling the discrete psychotic disorders' neurobiology and possibly contributing to the development of neurobiological hallmarks of treatment-resistant schizophrenia.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. de Bartolomeis A, De Simone G, De Prisco M, et al. Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment. Mol Psychiatry. 2023. PMID: 37085712. doi:10.1038/s41380-023-02065-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。